本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Redhill Biopharma Ltd

1.98
+0.06623.46%
盘前1.990.00000.00%08:52 EDT
成交量:4.02万
成交额:7.84万
市值:346.90万
市盈率:-0.30
高:2.03
开:1.89
低:1.85
收:1.91
数据加载中...
2019/08/06

SEC问询函

[Cover]Correspondence
2019/07/24

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/07/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/17

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/15

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]